PT Maja Agung Latexindo TbkISX:SURI 28 EBIT per Share is Rp-0.02 as of Mar. 2026. GuruFocus rates ISX:SURI with a GF Score™ of 28/100. The stock has 2 warning signs investors should review. Among 687 Medical Devices & Instruments companies, PT Maja Agung Latexindo Tbk ranks worse than 61.86% on this metric.
PT Maja Agung Latexindo Tbk's EBIT per Share for the
three
months ended in Mar. 2026 was Rp0.74.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was Rp-0.02.
During the past 3 years, the average EBIT per Share Growth Rate was 0.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for PT Maja Agung Latexindo Tbk's EBIT per Share or its related term are showing as below:
ISX:SURI'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -33.4 Med: -16.25 Max: 0.9
Current: 0.9
During the past 6 years, the highest 3-Year average EBIT per Share Growth Rate of PT Maja Agung Latexindo Tbk was 0.90% per year. The lowest was -33.40% per year. And the median was -16.25% per year.
ISX:SURI's 3-Year EBIT Growth Rate is ranked worse than 61.86% of 687
companies
in the Medical Devices & Instruments industry
Industry Median: 9.4
vs ISX:SURI: 0.90
PT Maja Agung Latexindo Tbk (ISX:SURI) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
PT Maja Agung Latexindo Tbk EBIT per Share Related Terms
PT Maja Agung Latexindo Tbk EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp-0.02
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Maja Agung Latexindo Tbk (ISX:SURI) has a EBIT per Share of Rp-0.02 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on PT Maja Agung Latexindo Tbk and its competitors. According to the industry distribution chart, PT Maja Agung Latexindo Tbk ranks #425 out of 687 companies in the Medical Devices & Instruments industry, placing it in the top 61.9%.
Is PT Maja Agung Latexindo Tbk's EBIT per Share too high?
PT Maja Agung Latexindo Tbk's current EBIT per Share is Rp-0.02. Based on the distribution chart, PT Maja Agung Latexindo Tbk ranks #425 out of 687 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, PT Maja Agung Latexindo Tbk has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does PT Maja Agung Latexindo Tbk's EBIT per Share compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, PT Maja Agung Latexindo Tbk ranks #425 out of 687 companies for EBIT per Share. This places PT Maja Agung Latexindo Tbk in the lower half of its industry. The industry median EBIT per Share is 9.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.40, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on PT Maja Agung Latexindo Tbk and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Maja Agung Latexindo Tbk's current EBIT per Share is Rp-0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Maja Agung Latexindo Tbk stock overvalued right now?
PT Maja Agung Latexindo Tbk (ISX:SURI) has a current EBIT per Share of Rp-0.02. The current EBIT per Share is Rp-0.02. PT Maja Agung Latexindo Tbk's overall GF Score™ is 28/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For PT Maja Agung Latexindo Tbk (ISX:SURI), the current EBIT per Share is Rp-0.02 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PT Maja Agung Latexindo Tbk specializes in the production of latex gloves, made from natural rubber, and is a primary choice in the medical and industrial sectors. The company's business includes business of making rubber goods for health support needs, such as contraceptive gloves (birth control)/ condoms, pacifiers and compresses, medical rubber gloves, and urinary catheters (folley catheter). Its segments include Gloves and Concentrated latex.
28GF Score
Get the complete analysis for ISX:SURI
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:SURI has been successfully added to your 
